As a globally recognized disposable hypodermic needle manufacturer, Zhejiang SuJia Medical Device Co., Ltd. has been delivering precision-engineered sterile medical consumables since 1992. Headquartered at No. 168 Zhenxing Road, Jiaxing, Zhejiang, China, SuJia operates over 110,000 m² of Class 100,000 clean room production space and holds more than 80 patents across its product portfolio. The Medical Aesthetics Category represents one of SuJia's core growth segments, developed in response to rising global demand for minimally invasive aesthetic procedures that require the highest standards of needle sharpness, consistency, and sterile integrity.
A disposable sterile hypodermic needle is a single-use hollow needle manufactured from medical-grade stainless steel, designed for subcutaneous, intramuscular, or intradermal injections. In the context of medical aesthetics, hypodermic needles are employed to deliver dermal fillers, botulinum toxin, mesotherapy compounds, fat-dissolving agents, skin boosters, and various injectable vitamins or nutrients. Their single-use nature is not only a safety requirement under international medical device regulations but also a fundamental design principle: each needle leaves the production line individually packaged in a sterile barrier system and must not be reused under any clinical circumstance.
The term "sterile" refers to a validated state in which the needle is free from viable microorganisms, achieved through an internationally accepted sterilization process. For disposable sterile hypodermic needles manufactured at SuJia, ethylene oxide (EO) sterilization is the standard method applied to finished, sealed products. EO gas penetrates the primary packaging and achieves a Sterility Assurance Level (SAL) of 10⁻⁶, meaning the probability of a non-sterile unit in any given lot is no greater than one in one million — the global benchmark for sterile medical devices under ISO 11135 and ISO 11607.
Needle gauge follows a standardized inverse scale: the higher the gauge number, the finer the needle diameter. In medical aesthetics, practitioners commonly select gauges between 25G and 34G depending on the substance being injected and the target tissue depth. A 25G or 27G needle is suitable for thicker hyaluronic acid fillers in deep dermal layers, while a 30G or 32G needle provides the fine-caliber delivery required for superficial skin boosters or botulinum toxin. SuJia's sterile hypodermic needle range covers a comprehensive gauge spectrum to match these clinical demands.
The bevel — the angled cut at the tip of the needle — is classified by its geometry. A standard short bevel (approximately 12–18° angle) produces a sharp, durable tip suited for most injection techniques. A medium or long bevel (18–30°) enables easier skin penetration with reduced initial resistance, which is preferred for superficial mesotherapy or micro-needling injection protocols. SuJia employs precision three-face grinding and optical inspection to verify bevel angle accuracy and tip sharpness on every needle before packaging.
Wall thickness is a parameter rarely discussed but critically important in aesthetics practice. Thin-wall (TW) and extra-thin-wall (ETW) variants are engineered to increase the internal bore (inner diameter) without increasing the outer diameter, enabling faster flow of viscous substances while maintaining patient comfort. This is achieved by using higher-grade stainless steel — typically SUS304 or SUS316L — that maintains structural integrity at reduced wall dimensions.
Needle length is specified in millimeters and typically ranges from 4 mm to 90 mm across the full hypodermic product line. Aesthetic injections targeting the superficial dermis use 4–13 mm lengths, while deeper tissue applications or nerve block approaches may require 25–50 mm. SuJia's manufacturing flexibility as an experienced disposable hypodermic needle manufacturer allows custom length and gauge combinations to be produced in accordance with buyer specifications.
The cannula (hollow shaft) of a hypodermic needle is manufactured from medical-grade stainless steel conforming to ASTM F899 or equivalent international standards. SuJia sources controlled-purity steel tubing that undergoes incoming quality control inspection for dimensional tolerance, surface finish, and chemical composition. The hub — the plastic connector attaching the needle to a syringe — is produced from medical-grade polypropylene (PP) or ABS polymer, both of which are biocompatible materials tested under ISO 10993 (Biological Evaluation of Medical Devices).
Silicone coating applied to the outer surface of the cannula reduces insertion friction and improves the glide of the needle through tissue. The silicone used must meet food-contact and pharmaceutical-grade standards and must be applied uniformly without pooling at the bevel tip, which could compromise sharpness. SuJia's process engineers control coating viscosity, application speed, and curing temperature to ensure repeatable, verified coating performance across all production batches.
Adhesive bonding between the cannula and hub is another critical quality parameter. Inadequate bond strength can lead to needle separation during use — a serious safety event. SuJia uses UV-cured medical adhesives with validated pull-out force specifications tested in accordance with ISO 23908 and applicable national medical device standards. Each lot undergoes destructive bond strength sampling as part of final release testing.
SuJia's production of sterile disposable hypodermic needles follows a controlled, vertically integrated process. Raw steel tubing is cut to length, ground to the specified bevel angle, polished, inspected for tip sharpness and dimensional conformance, and then cleaned in a multi-stage ultrasonic washing system to remove metalworking residues. Hubs are injection-molded from pharmaceutical-grade polymer under controlled process parameters. Needle-to-hub assembly is performed in ISO Class 8 (equivalent to traditional Class 100,000) clean room environments to prevent particulate contamination prior to primary packaging.
Primary packaging — the peel-open pouch in direct contact with the sterile needle — is made from a medical-grade Tyvek/film combination that maintains sterile barrier integrity for the declared shelf life, typically five years from the date of manufacture. Secondary packaging provides additional physical protection and is labeled in accordance with EN ISO 15223-1 symbol standards, including the sterility symbol, use-by date, lot number, manufacturer identity, and single-use designation. The about us section of SuJia's website describes the company's standing as one of the first enterprises in China to pass NMPA GMP pilot acceptance — a testament to its manufacturing discipline.
In-process quality control checkpoints include optical bevel inspection via camera-based vision systems, dimensional measurement using laser micrometers, and functional flow-rate testing on sampled units. Finished product release is governed by a documented quality plan that references ISO 7864 (Sterile Hypodermic Needles for Single Use — Requirements and Test Methods) as the primary technical standard.
Ethylene oxide sterilization is the method of choice for heat-sensitive medical devices such as hypodermic needles assembled with polymer hubs. The sterilization cycle is developed and validated in accordance with ISO 11135, encompassing three core phases: qualification of the sterilization chamber (Installation Qualification / Operational Qualification / Performance Qualification, or IQ/OQ/PQ), bioburden monitoring on pre-sterilization product, and parametric release testing that confirms the cycle achieved the necessary EO concentration, temperature, humidity, and exposure time.
Post-sterilization, each batch undergoes residual EO testing to confirm that residual ethylene oxide and ethylene chlorohydrin levels on the finished product are within the limits set by ISO 10993-7. This is a non-negotiable requirement for regulatory submission in markets such as the European Union (under MDR 2017/745), the United States (FDA 510(k)), and China (NMPA). SuJia holds CE product certification obtained in 2004 and maintains ongoing regulatory compliance for export to more than 30 countries and regions.
Shelf-life validation — commonly referred to as accelerated aging and real-time aging studies — is conducted in accordance with ASTM F1980 and ISO 11607-1. Packaged samples are subjected to elevated temperature and humidity conditions to simulate multi-year aging, followed by sterile barrier integrity testing (dye penetration, bubble emission, peel strength). These studies establish the declared five-year shelf life printed on each carton.
The Medical Aesthetics Category at SuJia specifically addresses the technical requirements of aesthetic medicine, a field where precision, patient comfort, and procedural consistency are equally important to safety. Hypodermic needles in this segment are used across a broad spectrum of treatments including hyaluronic acid filler injection for volume restoration and contouring, botulinum toxin delivery for dynamic wrinkle reduction, platelet-rich plasma (PRP) therapy for skin rejuvenation, mesotherapy with custom cocktails of vitamins, minerals, and amino acids, lipolysis via phosphatidylcholine or deoxycholic acid delivery, and biorevitalization using polynucleotides or collagen stimulators.
Each application carries specific needle selection criteria. Filler injection techniques such as the linear threading, fanning, cross-hatching, and retrograde fill methods each place different mechanical demands on the needle. A retrograde technique, for example, requires the needle to maintain structural integrity while being withdrawn under lateral force, demanding adequate wall thickness and hub bond strength. Mesotherapy micro-injection grids require needles capable of repeated rapid insertions at very shallow angles — a use case that benefits from ultra-fine gauge and highly consistent bevel geometry.
The transition toward cannula-based filler delivery in some aesthetic protocols has not eliminated the clinical demand for hypodermic needles; rather, needles remain essential for entry-point creation, precise bolus injection, and all botulinum toxin applications where cannulas are not applicable. SuJia's product range supports both needle-only and needle-plus-cannula clinical workflows.
Products offered under SuJia's sterile disposable medical portfolio are designed and manufactured to satisfy the requirements of multiple international regulatory frameworks. ISO 13485 quality management system certification governs all design, production, and distribution processes and is the baseline requirement for medical device export to the EU, Canada, Australia, and most regulated markets. ISO 7864 provides the specific product standard for sterile hypodermic needles, covering dimensions, sharpness testing, sterility requirements, packaging, and labeling. The European CE marking under MDR 2017/745 requires a notified body review for Class IIa devices, which includes sterile hypodermic needles. FDA 510(k) clearance involves substantial equivalence demonstration to a legally marketed predicate device.
SuJia's R&D capabilities include a designated Macromolecule Medical Device Joint R&D Laboratory established in collaboration with Zhejiang University, allowing the company to stay ahead of evolving technical standards and develop next-generation needle technologies. The company was designated a National Key High-tech Enterprise and a High-tech Enterprise R&D Center of Zhejiang Province — recognition that supports its technical credibility in global procurement processes.
Sourcing decisions for sterile disposable medical products involve evaluating manufacturing capability, quality system maturity, regulatory status, supply chain reliability, and commercial terms. SuJia brings over three decades of production experience to each of these criteria. Founded in 1992 and operating as the originator of the disposable anesthesia puncture kit in China, the company has expanded its expertise across anesthesia, infusion, monitoring, pain management, and aesthetics product lines — all visible in the full product range organized by clinical category.
The company's 800 million USD annual sales figure and export presence across 30+ countries reflect a production scale that ensures consistent component supply, stable raw material sourcing contracts, and the manufacturing volume necessary to support large-batch procurement demands from hospitals, distributors, and private aesthetic clinic chains. Over 180 professional technicians are employed in quality, engineering, and regulatory roles, ensuring that the gap between design specification and delivered product quality remains tightly controlled.
For buyers sourcing in the infusion category or general anesthesia category alongside aesthetics products, SuJia offers the advantage of consolidated supplier qualification — a single audit, a single quality agreement, and a single regulatory submission package covering multiple product lines. The same applies to buyers of regional anesthesia products, pain management devices, monitoring consumables, or nursing care category items who wish to streamline their supply base.
SuJia currently offers two primary product lines within the Medical Aesthetics Category. The first is a Disposable Sterile Hypodermic Needle designed for standard aesthetic injection applications, covering a broad gauge and length matrix with standardized Luer slip or Luer lock hub configurations. The second is an alternative Disposable Sterile Hypodermic Needle variant optimized for specific procedure types, differing in bevel geometry, wall specification, or hub configuration to meet particular clinical workflow requirements.
Both products are manufactured to the same quality and sterility standards, packaged in individual sterile pouches, and available for private-label, OEM, and branded supply arrangements. Custom gauge, length, hub color-coding (per ISO 6009 color code system for needle gauge identification), and packaging specifications can be accommodated subject to minimum order quantities and tooling requirements. Detailed product datasheets and technical files are available upon request through the contact page.
Each individual needle is packaged in a peel-open sterile barrier pouch constructed from medical-grade Tyvek and transparent film, both materials complying with ISO 11607 performance requirements. The pouch label includes: product name and description, gauge and length in ISO color-coded format, lot number, manufacture date, expiry date, sterilization method indicator, single-use symbol (per ISO 15223-1), and manufacturer name and address.
Secondary (carton) and tertiary (shipper) packaging are designed to maintain primary package integrity during transportation and storage under the conditions defined in ASTM D4169 distribution simulation testing. Products are stored and shipped at ambient temperature (15–30°C) and controlled relative humidity (below 75% RH) conditions, with clear storage instruction labeling to support clinic and hospital inventory management practices.
For procurement teams, distributors, and aesthetic clinic procurement managers seeking a verified sterile hypodermic needle supplier with proven manufacturing infrastructure and international regulatory standing, SuJia provides a dedicated global sales team reachable at global@zjsj.com.cn or by telephone at +86-573-82222666. The company's global sales network already spans 30+ countries and 100+ cooperation partners, providing a proven framework for new market entry and private-label partnership development.
Technical inquiries regarding custom specifications, regulatory documentation packages (including CE technical files, FDA 510(k) summaries, or ISO 13485 certificates), and product sampling requests can all be submitted through the contact page. SuJia's team provides response within one business day for sample requests and within three business days for custom specification feasibility assessments. For the latest company developments, exhibition appearances, and new product launches, visit the company news and exhibition information sections of the website.
